JPH0349923B2 - - Google Patents
Info
- Publication number
- JPH0349923B2 JPH0349923B2 JP17683383A JP17683383A JPH0349923B2 JP H0349923 B2 JPH0349923 B2 JP H0349923B2 JP 17683383 A JP17683383 A JP 17683383A JP 17683383 A JP17683383 A JP 17683383A JP H0349923 B2 JPH0349923 B2 JP H0349923B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- adriamycin
- anthracycline antibiotic
- divema
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003817 anthracycline antibiotic agent Substances 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 14
- 229920001577 copolymer Polymers 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 30
- 230000001093 anti-cancer Effects 0.000 description 19
- 238000000862 absorption spectrum Methods 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 229940009456 adriamycin Drugs 0.000 description 15
- 239000000047 product Substances 0.000 description 12
- DQJJMWZRDSGUJP-UHFFFAOYSA-N ethenoxyethene;furan-2,5-dione Chemical compound C=COC=C.O=C1OC(=O)C=C1 DQJJMWZRDSGUJP-UHFFFAOYSA-N 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 7
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 7
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 206010000830 Acute leukaemia Diseases 0.000 description 2
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000011654 childhood malignant neoplasm Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- GUGHGUXZJWAIAS-QQYBVWGSSA-N Daunorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 GUGHGUXZJWAIAS-QQYBVWGSSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000012607 strong cation exchange resin Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960000834 vinyl ether Drugs 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17683383A JPS6067490A (ja) | 1983-09-24 | 1983-09-24 | アントラサイクリン系抗生物質誘導体及びその製造方法 |
| US06/651,343 US4520162A (en) | 1983-09-24 | 1984-09-17 | Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17683383A JPS6067490A (ja) | 1983-09-24 | 1983-09-24 | アントラサイクリン系抗生物質誘導体及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6067490A JPS6067490A (ja) | 1985-04-17 |
| JPH0349923B2 true JPH0349923B2 (enrdf_load_stackoverflow) | 1991-07-31 |
Family
ID=16020629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17683383A Granted JPS6067490A (ja) | 1983-09-24 | 1983-09-24 | アントラサイクリン系抗生物質誘導体及びその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6067490A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63307825A (ja) * | 1987-06-08 | 1988-12-15 | Nippon Beet Sugar Mfg Co Ltd | 抗腫瘍剤及びその製法 |
| US5378456A (en) * | 1993-03-25 | 1995-01-03 | American Cyanamid Company | Antitumor mitoxantrone polymeric compositions |
-
1983
- 1983-09-24 JP JP17683383A patent/JPS6067490A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6067490A (ja) | 1985-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08502053A (ja) | アルジネート‐生物活性剤配合体 | |
| JP2787241B2 (ja) | 白金―ポリマー錯塩および抗腫瘍剤としてのそれらの用途 | |
| Ouchi et al. | Synthesis and antitumor activity of chitosan carrying 5‐fluorouracils | |
| Hirano et al. | Synthesis of antitumor‐active conjugates of Adriamycin or daunomycin with the copolymer of divinyl ether and maleic anhydride | |
| EP0028641B1 (en) | Hydroxyalkyl starch drug carrier | |
| JPH03501867A (ja) | デキストラン骨格を有するヨウ素化ポリマー、その製法及び造影剤としての用途 | |
| JP2749295B2 (ja) | 高分子白金錯化合物、その製造方法及びそれを有効成分とする抗ガン剤 | |
| JPH0349923B2 (enrdf_load_stackoverflow) | ||
| US5378456A (en) | Antitumor mitoxantrone polymeric compositions | |
| WO1987007142A1 (en) | Novel complexes, process for their preparation, and medicinal use of them | |
| JPS6232172B2 (enrdf_load_stackoverflow) | ||
| JPH04288304A (ja) | 高分子マイトマイシンｃ誘導体及びその製造方法 | |
| JP2545729B2 (ja) | メトトレキセート誘導体とピラン共重合体の高分子結合体及びその製造方法 | |
| JP3111099B2 (ja) | 水溶性高分子化薬剤の製造法 | |
| JPH0448778B2 (enrdf_load_stackoverflow) | ||
| US4520162A (en) | Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof | |
| JPS6330886B2 (enrdf_load_stackoverflow) | ||
| JPS6230999B2 (enrdf_load_stackoverflow) | ||
| JP6872216B2 (ja) | イミノ二酢酸を側鎖に有する親水性高分子及びその使用 | |
| JPS6232200B2 (enrdf_load_stackoverflow) | ||
| JP2550261B2 (ja) | 酸化カルボキシメチルマンノグルカンードキソルビシン複合体 | |
| KR0169195B1 (ko) | PVMA-Ara-C 결합체 | |
| KR100479331B1 (ko) | 수용성 플러렌-디엔에이 복합체 및 이의 제조방법 | |
| JPH0699501B2 (ja) | 高分子アラビノフラノシルシトシン誘導体及びその製造方法 | |
| CN120361236A (zh) | 促进伊曲康唑吸收的助剂组合 |